PREcoopERA (GBG 112)

EU CT-Nummer: 2022-503013-32

NCT05896566

  1. Startpage
  2. Trials
  3. PREcoopERA

Introduction

A Window-of-Opportunity trial of giredestrant +/- triptorelin vs. anastrozole + triptorelin in premenopausal patients with ER-positive/HER2-negative early breast cancer

Sponsor: ETOP IBCSG Partners Foundation

Design

Randomized (2:2:1), multicenter, open-label, three-arm (A, B, C), Window-of-Opportunity (WOO) trial to evaluate the activity and safety of giredestrant (A) versus giredestrant plus triptorelin (B) versus anastrozole plus triptorelin (C).

 

Study Design Precoopera

Study Design Precoopera

Contact

Project management